Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: scientifically acceptable study report

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1976
Report date:
1976

Materials and methods

Principles of method if other than guideline:
According to BASF-internal standard. The study was conducted before the OECD guideline 401 was first adopted.
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Morpholinium toluene-4-sulphonate
EC Number:
237-301-3
EC Name:
Morpholinium toluene-4-sulphonate
Cas Number:
13732-62-2
Molecular formula:
C7H8O3S.C4H9NO
IUPAC Name:
morpholin-4-ium 4-methylbenzenesulfonate
Test material form:
other: aqueous solution
Details on test material:
Name of the test substance used in the study report: Haerter 527 fluessig; Morpholinium-o/p-toluolsuIfonat (approx. 75 % aqueous solution)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
Mean body weights: males 195 g, females 170 g
The animals were offered a standardized animal laboratory diet.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
The test concentrations used were 68.1 % and 100% (v/v); aqueous solution.
Doses:
6810 and 10000 ul/kg
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
approximate LD50
Effect level:
> 10 000 other: µl/kg
Based on:
test mat.
Mortality:
6810 ul/kg: no deaths after 14 days
10000 ul/kg: 1/10 animals died (after 24 hours)
Clinical signs:
other: dyspnea, apathy, staggering, tonic-clonic convulsions, diarrhea, urine intense yellow, poor general state
Gross pathology:
heart: acute dilatation, acute congestive hyperemia; intestine: atonic, diarrheic content

Any other information on results incl. tables

In the report, it was stated that a 75 % aqeous solution was tested so that an approximated value of 7500 mg/kg can be assumed.

Applicant's summary and conclusion